Advertisement
Annals
Established in 1927 by the American College of Physicians
:
Advanced search

Cover Image   
box In this Issue
  arrow Articles
  arrow Reviews
  arrow Perspectives
  arrow Medicine and Public Issues
  arrow Editorials
  arrow On Being a Doctor
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Ancillary Content
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 
box In this Issue
  arrow Articles
  arrow Reviews
  arrow Perspectives
  arrow Medicine and Public Issues
  arrow Editorials
  arrow On Being a Doctor
  arrow Letters
  arrow Medical Writings: Book Notes
  arrow Ancillary Content
  arrow PDF of Contents
box Services
  arrow Subscribe
  arrow One-time access
  arrow Activate online subscription
  arrow Access Personal Archive
 

TABLE OF CONTENTS

15 April 2008 Volume 148 Issue 8
< Previous Issue  |  Next Issue >
Clear

Articles Back

Susan Davis, Mary-Anne Papalia, Robert J. Norman, Sheila O'Neill, Margaret Redelman, Margaret Williamson, Bronwyn G.A. Stuckey, John Wlodarczyk, Karen Gard'ner, and Andrew Humberstone

Davis and colleagues evaluated the effects of 3 doses of exogenous testosterone and placebo, all administered with a metered-dose transdermal spray, on sexual function. They randomly assigned 261 premenopausal women who reported a decrease in satisfying sexual activity and had a morning serum free testosterone level less than 3.8 pmol/L (<1.1 pg/mL). After 16 weeks, the daily 90-µL dose of transdermal testosterone improved self-reported sexual satisfaction by a mean of 0.8 satisfactory sexual event per month. The rate with higher and lower testosterone doses did not differ from the rate with placebo.

Abstract | Full Text | PDF | Audio Summary

Barbara J. Turner, Christopher S. Hollenbeak, Mark Weiner, Thomas Ten Have, and Simon S.K. Tang

Little is known about the quality of care received by patients with multiple unrelated comorbid conditions. The authors examined the electronic medical records of 15 459 patients with uncontrolled hypertension at 6 primary care practices. Most patients had 2 or more comorbid conditions unrelated to hypertension, such as arthritis, gastroesophageal reflux, or thyroid disease. At office visits, clinicians were less likely to intensify treatment for uncontrolled hypertension in patients with multiple unrelated conditions.

Abstract | Full Text | PDF


Reviews Back

Robert A. Brodsky

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematopoietic stem-cell disorder caused by a mutation that leads to increased susceptibility to complement-induced hemolysis. An expensive but highly effective drug markedly reduces the activity of PNH. This narrative review describes the history of the condition, its molecular biology and clinical manifestations, diagnostic testing, and therapeutic options.

Full Text | PDF | CME

Matthew T. James, Joslyn Conley, Marcello Tonelli, Braden J. Manns, Jennifer MacRae, Brenda R. Hemmelgarn for the Alberta Kidney Disease Network

Catheter-related infections are a major cause of illness among patients receiving long-term hemodialysis with a central venous catheter. This systematic review found 16 randomized trials that assessed the potential benefits of applying antibiotics topically to the catheter exit site or instilling them intraluminally into the catheter. Compared with no antibiotic therapy, prophylaxis with either topical or intraluminal antibiotics reduced bloodstream infections and the need to remove the catheter because of infection.

Abstract | Full Text | PDF | CME


Perspectives Back

Kimberly A. Workowski, Stuart M. Berman, and John M. Douglas, Jr.

Prevention and control of gonorrhea is an important public health concern. Over the past 60 years, the increasing prevalence of multiple antibiotic-resistant strains of Neisseria gonorrhoeae has begun to limit therapeutic options. Workowski and colleagues describe comprehensive strategies for sustaining the effectiveness of antimicrobials and maintaining control over endemic gonorrhea.

Abstract | Full Text | PDF


Medicine and Public Issues Back

Aaron S. Kesselheim and Niteesh K. Choudhry

In response to increasing prescription drug costs, more U.S. patients and policymakers are importing less-expensive pharmaceuticals from other countries. Federal legislators continue to debate whether to legalize importation. Three factors affect whether U.S. patients and policymakers can rely on other countries as sources of imported prescription drugs: the feasibility of strategies to ensure the safety of the product, how the import price compares with domestic prices, and how importation might affect the exporting country's pharmaceutical market.

Abstract | Full Text | PDF


Editorials Back

Rosemary Basson

Sexual dissatisfaction is highly prevalent among women, ranging from 17% to 25%. We know enough about its causes to formulate a logical approach to treating sexual dissatisfaction in women. In this issue, the article by Davis and colleagues suggests that transdermal testosterone might be used to manage sexual dissatisfaction in premenopausal women. Their study showed only very modest benefit of testosterone treatment, and the authors caution against the widespread adoption of testosterone therapy in sexually dissatisfied premenopausal women.

Full Text | PDF


On Being a Doctor Back

Katherine Chang Chretien

Long before my daughter was born, I acquired a top-of-the-line breast pump. My maternity leave was over when Jolie was 11 weeks old, and it was time to bring my pumping to work. I had to plunge right into patients, housestaff, actual medicine, while I contended with pumping and separation anxiety. My days, which had always been busy, were now nonstop action—I saw time in an entirely different light: the vanishing minutes of a working mother.

Full Text | PDF


Letters Back

Could Increasing the Duration of Triple Therapy Be a Clinically Useful Strategy?

    Xavier Calvet, Albert Villoria, and Mercedes Vergara

    Full Text | PDF

    Lorenzo Fuccio, Rocco Maurizio Zagari, and Franco Bazzoli—RESPONSE

    Full Text | PDF

When to Switch Therapy in Patients with Severe Community-Acquired Pneumonia

    Eric M. Mortensen, Marcos I. Restrepo, and Antonio Anzueto

    Full Text | PDF

    Alpesh N. Amin and Michael J. Pistoria—RESPONSE

    Full Text | PDF

Does Tiotropium Reduce Hospitalizations in Chronic Obstructive Pulmonary Disease?

    Timothy J. Wilt, Dennis Niewoehner, Roderick MacDonald, and Robert L. Kane—RESPONSE

    Full Text | PDF

How to Improve Coordination of Care

Is It Safe to Conclude that Beers Criteria Medications Led to Few Adverse Events?

    Adam Golden, Mark H. Beers, and Donna M. Fick

    Full Text | PDF

    Daniel S. Budnitz, Nadine Shehab, Scott R. Kegler, and Chesley L. Richards—RESPONSE

    Full Text | PDF

Are Pay-for-Performance Programs a Threat to Medical Professionalism?

    Richard L. Neubauer and Lois Snyder—RESPONSE

    Full Text | PDF

Memantine-Induced Hepatitis with Cholestasis in a Very Elderly Patient

    Nicola Ferrara, Graziamaria Corbi, Annalisa Capuano, Amelia Filippelli, and Francesco Rossi

    Full Text | PDF

Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy

    David M. You, M. Alaric Franzos, and Robert P. Holman

    Full Text | PDF

Overanticoagulation with Coumarin and Cutaneous Azole Therapy

    Jean-François Alexandra, Eric Pautas, Isabelle Gouin-Thibault, Virginie Siguret, and Marie-Anne Loriot

    Full Text | PDF

Correction: Improved Diagnostic Evaluation of Suspected Tuberculosis

Correction: Achieving a High-Performance Health Care System with Universal Access



Medical Writings: Book Notes Back

Woodruff J. English

Full Text | PDF

Krista M. Johnson and Holly J. Humphrey

Full Text | PDF


Ancillary Content Back

Full Text



 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2009 by the American College of Physicians.